TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Change from baseline Timeline Followback (TLFB) at 6 months post-baseline
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change from baseline Timeline Followback (TLFB) at 12 months post-baseline
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change from baseline Brief Young Adult Alcohol Consequences Questionnaire (B-YAACQ) at 6 months post-baseline
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change from baseline Brief Young Adult Alcohol Consequences Questionnaire (B-YAACQ) scores at 12 months post-baseline
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Daily minutes in sedentary behavior
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Successful subretinal insertion of the robot-held 41G needle
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Stable subretinal position of the needle for at least 3 minutes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change from baseline in average Visual Analogic Scale score of subjects' perceptions of asthma symptoms after 14 days of treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in rescue medication use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in Asthma Quality of Life Questionnaire (AQLQ) score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Biodistribution of 68Ga-HTK03149
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in PD1 from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in TIGIT from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in frequency of CD4 Tem cells from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in CD4 Treg/Tem ratio from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in scores of the Montreal Cognitive Assessment (MoCA) test
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Fatigue assessment Scale (FAS)
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Number of new SARS-CoV-2 cases at 21 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Number of participants with severe COVID pneumonia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in IL10 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in RANKL levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in RFA levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinically significant changes from baseline in systolic blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Clinically significant changes from baseline in complete blood count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Number of steatotic patients accessing the emergency room
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diabetes Knowledge
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: RSV-A neutralizing titers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: RSV-B neutralizing titers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Proportion of minor and major bleeds
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Blood perfusion of the brain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change in quality of life (EORTC QLQ C30)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in quality of life (EORTC QLQ BR23)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Attitudes toward Sexual Partner Concurrency
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: cough efficacy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Participation rate of laughter-imitation therapy (LIT)
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Compliance rate of laughter-imitation therapy (LIT)
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Acceptance of laughter-imitation therapy (LIT)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Improvement in systemic hemodynamics
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: High-risk driving events
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Experience with inhospital aerobic interval training
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Nature, incidence, and severity of any DLTs
Endpoint domain: Adverse events/effects
Primary endpoint: Determination of the MTD and/or RP1bD(s)
Endpoint domain: Adverse events/effects
Primary endpoint: Objective Response Rate (ORR) mRESIST v1.1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Coronary fraction flow reserve (FFR) value
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Quality of life at home
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Frequency of child maltreatment
Endpoint domain: Adverse events/effects
Primary endpoint: EDI change after caffeine citrate loading dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: EDI change after caffeine citrate maintenance dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: EDI change after caffeine citrate cessation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum scapular length
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Scapular breadth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum length of spine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Six-Month Progression-Free Survival (PFS)
Endpoint domain: Mortality/survival
Primary endpoint: Measurement of disease progression by weight measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Measurement of disease progression by detecting blood in stool
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Measurement of disease progression by serum glucose measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Area under the Curve (AUC0-inf)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Urinary Incontinence Diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Pelvic Floor Distress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Pelvic Floor Impact
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Serum 25-hydroxy vitamin D level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Chalder scale scores
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: UCDVA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of Cognitive decline
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Quality of life indicator measured by the EQ-5D-3L
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Visual analogue scale score (EQ-VAS)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Disability and functional limitations according to the WG-SS
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Pierce Suicide Intent Scale (SIS)
Endpoint domain: Adverse events/effects
Primary endpoint: Occurrence of death after surgery
Endpoint domain: Mortality/survival
Primary endpoint: Occurrence of acute myocardial infarction after surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Occurrence of a stroke after surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in Parent Acculturative stress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Youth Acculturative stress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in individual resilience
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in PROMIS Global Health
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Suicidal Ideation and Behavior
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean score on the Authentic Happiness Inventory (AHI)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Objective Response Rate (ORR) at 6 Months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Objective Response Rate (ORR) at 12 Months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Number of Participants With any Adverse Events of Special Interest (AESI)
Endpoint domain: Adverse events/effects
Primary endpoint: Post Traumatic Stress Disorder symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Adverse events and/or serious adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Change in eGFR Value
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Delay in follicular rupture
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Concentration of UPA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Score of ESRD-AQ
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Score of SOC
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Average motor conduction latency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Ad libitum meal consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percentage of Seropositive Participants for Each of the 4 Dengue Virus Serotypes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Rheumatoid arthritis flare-up
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Oxygenation saturation index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: End-of-session Carbon Monoxide
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cigarette Discrimination Accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Personal Health Questionnaire Depression Scale score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Generalized Anxiety Disorder 7-item (GAD-7) score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Quick Inventory of Depressive Symptomatology (QIDS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in haemoglobin level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Percentage of participants with problematic spasticity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Average Number of Planned WBH Sessions Completed
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Range of scapular downward rotation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pulse pressure prediction of fluid responsiveness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Stroke volume prediction of fluid responsiveness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Triceps muscle strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum work (watts)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VO2peak (ml/kg/min)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Parent-reported Child Behavioural Problems
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Bioequivalence between tasimelteon formulations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety and Tolerability of tasimelteon formulations
Endpoint domain: Adverse events/effects
Primary endpoint: out-of field nodal recurrence rate at 2 years
Endpoint domain: Mortality/survival
Primary endpoint: acute Graft Versus Host Disease (aGVHD)
Endpoint domain: Adverse events/effects
Primary endpoint: antiDFS70 antibodies titre
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Assessment of lung metastases
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Foam Sanitizer User Touch and Feel Experience
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Foam Sanitizer User Preference
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Foam Sanitizer User Preference 2
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Antimullerian hormone level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI-2K)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Timed stand up and go test score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Berg Balance scale score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Fall risk test score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: high-sensitive Troponin I levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Oncologic safety
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: ctDNA changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Modified Rankin Scale (mRS) 0-1 or return to baseline mRS at 90 days
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Activity pacing improvement
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Proportion of participants achieving a score of 0 or 1 with at least a two-grade improvement in glabellar line severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the ROC curve (AUC) of the TFPI-1 biomarker
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: T cell lymphocyte profiles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: SLEDAI Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of postoperative ED
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants With RT-PCR Confirmed Symptomatic COVID-19 (PEP)
Endpoint domain: Mortality/survival
Primary endpoint: Percentage of Participants With RT-PCR Confirmed Symptomatic COVID-19 (PrEP)
Endpoint domain: Mortality/survival
Primary endpoint: Solicited Injection Site Reactions (PEP, PrEP)
Endpoint domain: Adverse events/effects
Primary endpoint: Participants With at Least 1 Treatment Emergent Adverse Events (PEP, PrEP)
Endpoint domain: Adverse events/effects
Primary endpoint: Family's communication knowledge
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Healthy parenting behavior measurement #1
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Concentration of blood dp-ucMGP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concentration of blood total osteocalcin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concentration of blood menaquinones (vitamin K2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of adults with Subjective Cognitive Decline (SCD) or Mild Cognitive Impairment (MCI) at risk for dementia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Proper/Improper use of inhaler
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Myocardial inflammation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Anti-SARS-CoV-2 spike protein total IgG
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Positive likelihood ratio of the algorithm classification
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anxiety tendency
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Incidence of postoperative hypotension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Hemodynamic changes with treatment of hypotension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Seroprevalence of antibodies to selected AAV serotypes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: EEG index of time expectation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Breastfeeding success measured by LATCH
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Newborn stress levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gamma camera-based whole-body 99mTc-RM26 uptake value (%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SPECT-based 99mTc-RM26 value in tumor lesions (counts)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change from baseline radicular pain score at 2 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline radicular pain score at 3 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Two-minute Walk Test (2MWT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area of CoP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total distance covered by the CoP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Completion of COVID-19 Test After First Randomization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Average strategy sensitivity over time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum average strategy sensitivity over time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HDRS-17 change
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Perceived Acceptability
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Perceived Appropriateness
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Perceived Feasibility
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Changes in Epilepsy diary
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Improvement of pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Improvement of stiffness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Composite events of one-year Re-Hospitalization and all-cause death
Endpoint domain: Mortality/survival
Primary endpoint: Area under the receiver operating characteristic curve (AUC) for TRG prediction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of TRG prediction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Social physique anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Physical self-esteem
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Pharmacokinetics of co-administration of rosuvastatin and eltrombopag
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of surveys/tasks returned in period 1
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Proportion of surveys/tasks returned in period 2
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Proportion of surveys/tasks returned in period 3
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Proportion of surveys/tasks returned in period 4
Endpoint domain: Resource use
Endpoint subdomain: Other resource use